Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Butyl bromide | HCID 8002 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 22914212 | HCID 22914212 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 22914465 | HCID 22914465 | 49% |
Reaction Steps
1.17 ml (6.8 mmol) of N-ethyldiisopropylamine and 0.55 ml (5.1 mmol) of butyl bromide were added to a solution of 0.54 g (1.7 mmol) of 3-(5-aminomethyl-1,2,4-oxadiazol-3-yl)-5-methyl-5,6-dihydro-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepin-6-one in 20 ml of dimethylformamide and the mixture was stirred at 70° for 1 hour. The reaction solution was subsequently evaporated, whereupon the residue was partitioned between methylene chloride and 2N sodium carbonate solution. The aqueous phase was washed three times with methylene chloride. The organic phases were dried with magnesium sulfate, filtered and evaporated. The residue obtained was chromatographed (silica gel, methylene chloride/methanol/aqueous ammonia 110:10:1). There were obtained 310 mg (47%) of 3-(5-butylaminomethyl-1,2,4-oxadiazol-3-yl)-5-methyl-5,6-dihydro-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepin-6-one as a colourless foam, Rf=0.73 (silica gel, methylene chloride/methanol/aqueous ammonia 110:10:1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-99d01abcfab1413e995b8b312941925f |
|---|
| Source note | uspto-grants-1997_09 |
|---|